Ozagrel Na intravenous infusion 20mg “Towa”, manufactured by Towa Pharmaceutical, contains sodium ozagrel, a thromboxane A2 synthetase inhibitor. This injectable medication, with YJ code 3999411A3095 and standard 20mg 1mL 1 tube, is used to inhibit platelet aggregation and improve cerebral blood flow.
Ozagrel Na intravenous infusion 20mg “Towa”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →